Biomx Inc

General ticker "PHGE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $10.2B

Biomx Inc does not follow the US Stock Market performance with the rate: -22.3%.

Estimated limits based on current volatility of 6.2%: low 0.56$, high 0.63$

Factors to consider:

  • Current price 76.1% below estimated low
  • Earnings for 6 months up through Q2 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.28$, 5.37$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.19$, 5.02$]

Financial Metrics affecting the PHGE estimates:

  • Negative: Non-GAAP EPS, $ of -4.62 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -57.45 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term PHGE quotes

Long-term PHGE plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $35.46MM $27.22MM $27.68MM
Operating Income $-35.46MM $-27.22MM $-27.68MM
Non-Operating Income $-0.70MM $-1.03MM $1.54MM
Interest Expense $0.70MM $2.07MM $2.40MM
R&D Expense $22.68MM $16.24MM $19.04MM
Income(Loss) $-36.16MM $-28.25MM $-26.15MM
Taxes $0.07MM $0.07MM $0.02MM
Profit(Loss) $-36.23MM $-28.32MM $-26.17MM
Stockholders Equity $47.53MM $21.04MM $3.08MM
Inventory $0.11MM $0.40MM $0.00MM
Assets $77.99MM $45.53MM $25.03MM
Operating Cash Flow $-27.57MM $-29.09MM $-21.29MM
Capital expenditure $3.68MM $0.11MM $0.05MM
Investing Cash Flow $16.17MM $-2.11MM $1.95MM
Financing Cash Flow $37.28MM $0.29MM $2.90MM
Earnings Per Share* $-13.93 $-9.49 $-5.10

* EPS are Split Adjusted, recent splits may be reflected with a delay.